Photo from academic.microsoft.com
Despite a 5‐year overall survival rate of 58 per cent after liver resection for colorectal liver metastases (CLMs), more than half of patients develop recurrence, highlighting the need for accurate… Click to show full abstract
Despite a 5‐year overall survival rate of 58 per cent after liver resection for colorectal liver metastases (CLMs), more than half of patients develop recurrence, highlighting the need for accurate risk stratification and prognostication. Traditional prognostic factors have been superseded by newer outcome predictors, including those defined by the molecular origin of the primary tumour.
Keywords:
liver metastases;
biomarkers colorectal;
colorectal liver;
liver
Journal Title: British Journal of Surgery
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: British Journal of Surgery
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!